SAN DIEGO, June 24, 2013 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today announced that 14 additional hospitals across the country have adopted the ...

To view the multimedia assets associated with this release, please visit: http://www.multivu.com/mnr/53365-carefusion-unveils-pyxis-automated-medication-dispensing ...

The monotherapy trial suggested a confirmed overall-response rate of 46% and a disease-control rate of 93%. In combination with Keytruda, the confirmed overall-response rate was 71% and the ...

SAN DIEGO, Dec. 7 CareFusion (NYSE: CFN), a leading, global medical device company, today announced six new Pyxis® medication management products at the 44th American Society for Health System ...

CAMBRIDGE, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat ...

Pfizer darling Pyxis Oncology will advance its lineup of next-gen oncology antibody-drug conjugates (ADCs) with the help of a newly-appointed chief medical officer. ADC Therapeutics veteran Jay ...

Pyxis Oncology is aiming to close out a transformative 2021 with an IPO. Having licensed a pair of antibody-drug conjugates (ADCs) from Pfizer and raised a megaround to develop them, Pyxis is now ...

When patients begin receiving care at St. Luke's Same Day Surgery Center in April, they'll receive medications through a computerized pharmacy system that's been in use throughout St. Luke's Regional ...

CareFusion, a global medical device company, and Cerner Corp., a global provider of healthcare solutions and services, have announced an agreement to improve data communication between CareFusion ...

BD received a warning letter after the Food and Drug Administration found fault with the practices at a facility that manufactures Pyxis medication management system medical devices. The letter, which ...